Scheduled pain meds may improve recovery after vacuum birth

NCT ID NCT07534969

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether giving pain medication on a fixed schedule (every 8 hours) works better than waiting for women to ask for it after a vacuum-assisted delivery. 51 women participated, receiving either scheduled or on-demand acetaminophen and diclofenac. The goal was to see which approach reduces pain more effectively and improves satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acetaminophen and diclofenac
What this could lead to
If successful, this could establish a standard pain management protocol that reduces pain and improves satisfaction after vacuum-assisted delivery.
What could go wrong
This is a small, completed trial with only 51 participants, so results may not apply broadly. Pain relief differences may be minimal, and individual responses vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

51 people

The number who actually took part.

Started

Sep 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Women aged 18-45 who underwent vacuum-assisted delivery of a singleton pregnancy. Exclusion Criteria: 1. Allergy to acetaminophen or NSAIDs. 2. Chronic pain conditions (e.g., endometriosis, fibromyalgia). 3. Cesarean deliveries. 4. Multiple pregnancies. 5. Normal vaginal delivery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vacuum-assisted deliveries are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Meir Medical Center

    Kfar Saba, 4861027, Israel